X4 Pharmaceuticals Files Q1 2025 10-Q
Ticker: XFOR · Form: 10-Q · Filed: May 1, 2025 · CIK: 1501697
| Field | Detail |
|---|---|
| Company | X4 Pharmaceuticals, Inc (XFOR) |
| Form Type | 10-Q |
| Filed Date | May 1, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, pharmaceuticals, financials
TL;DR
X4 Pharma's Q1 2025 10-Q is in. Check financials and operations.
AI Summary
X4 Pharmaceuticals, Inc. filed its 10-Q for the period ending March 31, 2025. The company reported financial results for the first quarter of 2025, detailing revenue and other financial metrics. The filing also includes information on the company's business operations and legal proceedings.
Why It Matters
This filing provides investors with an update on X4 Pharmaceuticals' financial health and operational status for the first quarter of 2025, crucial for assessing the company's performance and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, X4 Pharmaceuticals is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Players & Entities
- X4 Pharmaceuticals, Inc. (company) — Filer of the 10-Q
- 20250331 (date) — End of reporting period
- 20250501 (date) — Filing date
- 61 NORTH BEACON STREET (location) — Company's business and mailing address
- BOSTON (location) — Company's city
- MA (location) — Company's state
- 02134 (location) — Company's zip code
FAQ
What were X4 Pharmaceuticals' reported revenues for the first quarter of 2025?
The filing indicates revenue figures for the period January 1, 2025 to March 31, 2025, under 'LicenseAndOtherRevenueMember' and 'ProductMember', but specific dollar amounts are not detailed in the provided header information.
What is the company's fiscal year end?
X4 Pharmaceuticals' fiscal year ends on December 31.
When was X4 Pharmaceuticals previously known as?
The company was formerly known as Arsanis, Inc., with a name change date of September 20, 2010.
What is the primary business of X4 Pharmaceuticals?
X4 Pharmaceuticals is in the business of Biological Products (No Diagnostic Substances), with SIC code 2836.
What is the SEC file number for X4 Pharmaceuticals?
The SEC file number for X4 Pharmaceuticals is 001-38295.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on May 1, 2025 regarding X4 Pharmaceuticals, Inc (XFOR).